ERBB2 and triple-negative breast carcinoma: Clinically, tumors are classified based on histopathological features and receptor status into hormone receptor-positive (estrogen receptor and/or progesterone receptor-positive), human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative breast cancer (TNBC) phenotypes.